ChinaPeptides: difference between revisions
Diff·revision 7 → 8·19:26, 4 Nov 2024
Difference between revision 7 and revision 8 of ChinaPeptides. 3 lines changed; the page grew by 747 bytes.
| Revision 7 — 05:19, 30 Oct 2024 RfC_Rasmus (talk) rv restoration of unsourced claim 1,725 bytes ±0 | Revision 8 — 19:26, 4 Nov 2024 DrTitration (talk) attribute claim in-text 2,472 bytes +747 | ||
|---|---|---|---|
| 10 | The organisation is one of twenty covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} | 10 | The organisation is one of twenty covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} |
| 11 | 11 | ||
| + | 12 | == Distribution and dispatch == | |
| + | 13 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. | |
| + | 14 | ||
| 12 | == References == | 15 | == References == |
| 13 | {{reflist}} | 16 | {{reflist}} |